$7.58
N/A
Last update: Oct 30, 4:00 PM
MapLight Therapeutics Inc
MPLTNASDAQ
MapLight Therapeutics (MPLT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.33 | $-1.08 | $-0.92 | $-1.36 |
| Actual | $-1.32 | $-1.34 | $-2.47 | $-37.18 |
| Surprise | +0.75% | -24.1% | -168.5% | -2633.8% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.13 | $-1.06 | $-1.28 | $-1.22 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-1.32 | $-1.33 | 0.75 % |
| Q1 | May 14, 2026 | $-1.34 | $-1.08 | -24.1 % |
| Q4 | Mar 26, 2026 | $-2.47 | $-0.92 | -168.5 % |
| Q3 | Dec 4, 2025 | $-37.18 | $-1.36 | -2633.8 % |
